TMCRThe Metals Royalty Company Inc.

🇺🇸 US
1.88
USD
Analysis Scores
Lothien Robustness Score?
48/100
Moderate
Neden bu skor?
Damodaran ?
30/100
DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
55/100
Piotroski ?
1/9
Weak
Previous period ROA data missing (C1 delta-ROA); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5); Previous year current ratio missing (C6); gross profit, revenue data missing → margin comparison unavailable (C8)
Graham ?
Negatif HBK
Company is loss-making (EPS = -0.2426 TL) — Graham formula requires positive earnings
Active Metric?
1/4
Confidence?
43%
Lothien Robustness Summary
28/100
Lothien Sağlamlık: Çok Zayıf (28/100)
Temel göstergelerin çoğu olumsuz. Lothien sağlamlık skoru düşük seviyede. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 3 | Negatif: 4 | Nötr: 1
Net Zarar
Son çeyrekte -$7M zarar açıklandı. Yatırımcı dikkatli olmalı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+35.2 arttı (-$10M → -$7M). Kısa vadede olumlu momentum.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-22608.4 düştü. Uzun vadede endişe verici.
3 Çeyrek Üst Üste Düşüş
Son 3 çeyrek üst üste kâr düşüyor. Aşağı trend endişe verici. Sonraki çeyreğe dikkat.
Negatif ROE
ROE: %-16.9. Şirket özsermayesini eritiyor.
Mevsimsel Toparlanma, Ama Trend Bozuk
Çeyreklik artış (%+35.2) ama yıllık bazda düşüş (%-22608.4). Mevsimsel toparlanma var ama uzun vadeli trend zayıf.
Özkaynak Büyümesi
Özkaynak çeyreklik %+183.9 arttı. Şirket içsel birikimle güçleniyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+15.5 artabilir (-$7M → -$6M).

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
151 days
Annual Volatility ?
%93.8
VaR 95% ?
%10.86
daily max loss
VaR 99% ?
%14.89
daily max loss
CVaR 95% ?
%13.01
expected loss (tail)
Max Drawdown ?
%88.7
01.05.2026 → 05.11.2026
Skewness ?
0.74
Parametrik%10.86
Historik%10.66
Cornish-Fisher%9.25
Return Distribution
Valuation
Potential?
+86.1%
ROIC ?
-9.7%
Debt Cycle?
Geç Genişleme
Balance Sheet Analysis? Q2026/9
Son 2 çeyrek ardışık zarar
Fiyat TRAMA-99 altında: %-50.0 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 3.76 USD
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %-16.9
ROE %-16.9 — negative return on equity.
Valuation
P/B Ratio 1.09x Sector: 4.55x
PD/DD 1.09x — sector median's (4.55x) well below. Cheap relative to book value.
Indebtedness
Current Ratio 1.67x
Current ratio 1.67x — can comfortably cover short-term debts.
Debt / Equity 0.35x
Low leverage — majority of assets financed by equity.
Interest Coverage -26.1x
Interest coverage -26.1x — critical level. Risk of difficulty in interest payments.
Growth
Net Profit Growth (YoY) %-22608.4
Loss %22608.4 increased — losses deepening.
Score Explanations
Lothien Robustness
48/100
Moderate robustness (48/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
+86.1%
Plus %86.1 expected value (3.63) vs current price comparison. 1/4 valuation models could be calculated. Model confidence %43.
Components: P/B target: 5.85
Damodaran Valuation
30/100
Weak
Dalio Risk Analysis
55/100
Moderate debt risk (55/100). Interest coverage ratio -26.1x — weak, fragile.
Leverage: 91/100 | Debt Service: 84/100 | Quality: 20/100
ROIC - Return on Capital
%-9.7
ROIC (%-9.7) cost of capital (10.8%) below → destroying value.
WACC: %10.8
Debt Cycle Phase
Geç Genişleme
Piotroski F-Score
1/9
Weak
Graham Intrinsic Value
—
Company is loss-making (EPS = -0.2426 TL) — Graham formula requires positive earnings
⚖️ Sector Comparison
P/B Ratio
1.09x vs 4.55x
Compared to sector %76 cheaper (by book value)
ROIC vs WACC
%-9.7 vs %10.8 WACC
ROIC 20.5 bps below cost of capital
TRAMA-99 Trend — Strong Downtrend
Price (1.88), TRAMA-99 line's %50.0 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 1.88
TRAMA: 3.76
Difference: %-50.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
Kurumsal Holdings — 13F (çeyreklik) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

TMCR — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.